CONCERT PHARMACEUTICALS, INC. Annual Share-based Payment Arrangement, Expense in USD from 2016 to 2021

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Concert Pharmaceuticals, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2016 to 2021.
  • Concert Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2022 was $1.9M, a 39.3% decline year-over-year.
  • Concert Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2022 was $8.74M, a 31.5% decline year-over-year.
  • Concert Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $12.6M, a 13.1% increase from 2020.
  • Concert Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2020 was $11.1M, a 7.62% increase from 2019.
  • Concert Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2019 was $10.3M, a 10.2% decline from 2018.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2021 $12.6M +$1.46M +13.1% Jan 1, 2021 Dec 31, 2021 10-K 2022-03-03
2020 $11.1M +$787K +7.62% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-03
2019 $10.3M -$1.17M -10.2% Jan 1, 2019 Dec 31, 2019 10-K 2021-02-25
2018 $11.5M +$3M +35.3% Jan 1, 2018 Dec 31, 2018 10-K 2020-02-27
2017 $8.5M +$3.43M +67.8% Jan 1, 2017 Dec 31, 2017 10-K 2019-02-28
2016 $5.07M Jan 1, 2016 Dec 31, 2016 10-K 2019-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.